Guido Stirnimann Selected Research

Guido Stirnimann Research Topics

6	Fibrosis (Cirrhosis) 01/2021 - 12/2014
3	Ascites 10/2022 - 02/2017
3	Liver Diseases (Liver Disease) 11/2021 - 01/2019
2	Autoimmune Hepatitis 01/2022 - 01/2019
2	Chemical and Drug Induced Liver Injury 01/2022 - 01/2010
2	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 01/2019
2	Amyloidosis 10/2021 - 11/2020
2	Liver Failure 01/2021 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 01/2020
2	Infections 12/2019 - 01/2019
2	Weight Loss (Weight Reduction) 01/2019 - 12/2018
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	Transthyretin-Related Hereditary Amyloidosis 10/2021
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021
1	Immunoglobulin Light-chain Amyloidosis 11/2020
1	Multiple Myeloma 11/2020
1	Hepatic Encephalopathy 10/2020
1	Hemophilia A (Haemophilia) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Blood Platelet Disorders (Thrombocytopathy) 01/2020
1	Renal Insufficiency (Renal Failure) 12/2019
1	Peritonitis 12/2019
1	Wounds and Injuries (Trauma) 12/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Sarcopenia 09/2018
1	Alcoholic Fatty Liver 09/2018
1	Intraabdominal Infections 01/2018
1	Venous Thromboembolism 01/2017
1	Pancreatitis 01/2017
1	Genetic Risk Score 01/2016
1	Weight Gain 01/2016
1	Obesity 01/2016
1	Drug-Related Side Effects and Adverse Reactions 12/2014
1	Hepatitis C 12/2014
1	Muscular Dystrophies (Muscular Dystrophy) 08/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2014
1	Brugada Syndrome 02/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2010

2	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
2	Prealbumin (Transthyretin)IBA 10/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	RamucirumabIBA 11/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Amyloidogenic ProteinsIBA 11/2020
1	AA amyloidosisIBA 11/2020
1	Vitamin K FDA Link 01/2020
1	von Willebrand FactorIBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	RivaroxabanIBA 12/2018
1	Vitamin D FDA LinkGeneric 09/2018
1	C-Reactive ProteinIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 12/2014
1	ombitasvirIBA 12/2014
1	DysferlinIBA 08/2014
1	Bortezomib (Velcade)FDA Link 08/2014
1	Proteasome InhibitorsIBA 08/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2010
1	Fluvoxamine (Luvox)FDA LinkGeneric 02/2010

6	Therapeutics 01/2022 - 12/2014
5	Bariatric Surgery 01/2020 - 01/2017
4	Liver Transplantation 01/2019 - 12/2014
2	Contraindications 10/2022 - 09/2018
2	Transjugular Intrahepatic Portasystemic Shunt 10/2022 - 02/2017
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2020 - 02/2017
2	Transplantation 09/2018 - 01/2016
1	Treatment Delay 10/2021
1	Catheters 12/2019
1	Duration of Therapy 12/2014